{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T07:27:28Z","timestamp":1772350048675,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41440-024-01943-w","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T03:36:19Z","timestamp":1728963379000},"page":"540-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Differences in target organ damage between captopril challenge test-defined definitive-positive and borderline-range groups among patients with primary aldosteronism"],"prefix":"10.1038","volume":"48","author":[{"given":"Naoki","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Haze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Tsuiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Kamemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Taura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Ichijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minemori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"JPAS II study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyo","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Kometani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeatsu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Kakutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhito","family":"Hirawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kihei","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"1943_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","volume":"107","author":"JW Conn","year":"1964","unstructured":"Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg. 1964;107:159\u201372.","journal-title":"Am J Surg"},{"key":"1943_CR2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"1943_CR3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327\u201359.","journal-title":"Endocr J"},{"key":"1943_CR4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","volume":"9","author":"NJ Brown","year":"2013","unstructured":"Brown NJ. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol. 2013;9:459\u201369.","journal-title":"Nat Rev Nephrol"},{"key":"1943_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2015.05.125","volume":"200","author":"S Bianchi","year":"2015","unstructured":"Bianchi S, Batini V, Bigazzi R. The renal effects of mineralocorticoid receptor antagonists. Int J Cardiol. 2015;200:20\u201324.","journal-title":"Int J Cardiol"},{"key":"1943_CR6","doi-asserted-by":"crossref","unstructured":"Manosroi W, Atthakomol P, Wattanawitawas P, Buranapin S. Differences in glycemic abnormalities between primary aldosteronism and essential hypertension: a systematic review and meta-analysis. Front Endocrinol. 2022;13:870047.","DOI":"10.3389\/fendo.2022.870047"},{"key":"1943_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11906-011-0182-2","volume":"13","author":"M Briet","year":"2011","unstructured":"Briet M, Schiffrin EL. The role of aldosterone in the metabolic syndrome. Curr Hypertens Rep. 2011;13:163\u201372.","journal-title":"Curr Hypertens Rep"},{"key":"1943_CR8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41440-021-00719-w","volume":"44","author":"T Haze","year":"2021","unstructured":"Haze T, Hatakeyama M, Komiya S, Kawano R, Ohki Y, Suzuki S, et al. Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism. Hypertens Res. 2021;44:1341\u201351.","journal-title":"Hypertens Res"},{"key":"1943_CR9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41440-023-01170-9","volume":"46","author":"T Haze","year":"2023","unstructured":"Haze T, Ozawa M, Kawano R, Haruna A, Ohki Y, Suzuki S, et al. Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism. Hypertens Res. 2023;46:1132\u201344.","journal-title":"Hypertens Res"},{"key":"1943_CR10","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1530\/EJE-22-0375","volume":"187","author":"SY Chen","year":"2022","unstructured":"Chen SY, Chen JY, Huang WC, Puar THK, Chin Kek P, Chueh JS, et al. Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis. Eur J Endocrinol. 2022;187:S47\u2013S58.","journal-title":"Eur J Endocrinol"},{"key":"1943_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6:51\u201359.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1943_CR12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","volume":"72","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Renal outcomes in medically and surgically treated primary aldosteronism. Hypertension. 2018;72:658\u201366.","journal-title":"Hypertension"},{"key":"1943_CR13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41440-023-01481-x","volume":"47","author":"T Haze","year":"2023","unstructured":"Haze T, Tamura K. Possible relationship between primary aldosteronism and small vessel disease. Hypertens Res. 2023;47:677\u201378.","journal-title":"Hypertens Res"},{"key":"1943_CR14","doi-asserted-by":"crossref","unstructured":"Qian N, Xu J, Wang Y. Stroke risks in primary aldosteronism with different treatments: a systematic review and meta-analysis. J Cardiovasc Dev Dis. 2022;9:300.","DOI":"10.3390\/jcdd9090300"},{"key":"1943_CR15","first-page":"195","volume":"186","author":"V-C Wu","year":"2021","unstructured":"Wu V-C, Wang S-M, Huang K-H, Tsai YC, Chan C-K, Yang S-Y, et al. Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments. Eur J Endocrinol. 2021;186:195\u2013205.","journal-title":"Eur J Endocrinol"},{"key":"1943_CR16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"1943_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ando.2016.05.001","volume":"77","author":"L Amar","year":"2016","unstructured":"Amar L, Baguet JP, Bardet S, Chaffanjon P, Chamontin B, Douillard C, et al. SFE\/SFHTA\/AFCE primary aldosteronism consensus: introduction and handbook. Ann Endocrinol. 2016;77:179\u201386.","journal-title":"Ann Endocrinol"},{"key":"1943_CR18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for the diagnosis and treatment of primary aldosteronism\u2013the Japan Endocrine Society 2009. Endocr J. 2011;58:711\u201321.","journal-title":"Endocr J"},{"key":"1943_CR19","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"1943_CR20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1507\/endocrj.EJ22-0585","volume":"70","author":"H Kobayashi","year":"2023","unstructured":"Kobayashi H, Nakamura Y, Abe M, Tanabe A, Sone M, Katabami T, et al. Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism. Endocr J. 2023;70:489\u2013500.","journal-title":"Endocr J"},{"key":"1943_CR21","doi-asserted-by":"publisher","unstructured":"Kobayashi H, Nakamura Y, Abe M, Nakamura T, Nozato Y, Izawa S, et al. Prevalence of unilateral hyperaldosteronism in primary aldosteronism: impact of a novel chemiluminescent immunoassay for measuring plasma aldosterone in Japan. Hypertens Res. 2024; https:\/\/doi.org\/10.1038\/s41440-024-01786-5.","DOI":"10.1038\/s41440-024-01786-5"},{"key":"1943_CR22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension. 2018;71:530\u201337.","journal-title":"Hypertension"},{"key":"1943_CR23","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41371-021-00595-4","volume":"36","author":"T Haze","year":"2022","unstructured":"Haze T, Yano Y, Hatano Y, Tamura K, Kurihara I, Kobayashi H, et al. Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function. J Hum Hypertens. 2022;36:904\u201310.","journal-title":"J Hum Hypertens"},{"key":"1943_CR24","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ekir.2020.06.012","volume":"5","author":"Y Kobayashi","year":"2020","unstructured":"Kobayashi Y, Haze T, Yano Y, Tamura K, Kurihara I, Ichijo T, et al. Associations between changes in plasma renin activity and aldosterone concentrations and changes in kidney function after treatment for primary aldosteronism. Kidney Int Rep. 2020;5:1291\u201397.","journal-title":"Kidney Int Rep"},{"key":"1943_CR25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2021.03.033","volume":"324","author":"T Haze","year":"2021","unstructured":"Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, et al. Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism. Atherosclerosis. 2021;324:84\u201390.","journal-title":"Atherosclerosis"},{"key":"1943_CR26","doi-asserted-by":"crossref","unstructured":"Mulatero P, Paglieri C, Morello F, Chiandussi L. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002; 40:897\u2013902.","DOI":"10.1161\/01.HYP.0000038478.59760.41"},{"key":"1943_CR27","volume":"13","author":"KF Hua","year":"2022","unstructured":"Hua KF, Wu YH, Zhang ST. Clinical diagnostic value of liquid chromatography-tandem mass spectrometry method for primary aldosteronism in patients with hypertension: a systematic review and meta-analysis. Front Endocrinol. 2022;13:1032070.","journal-title":"Front Endocrinol"},{"key":"1943_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"key":"1943_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ajkd.2010.12.026","volume":"58","author":"SL White","year":"2011","unstructured":"White SL, Yu R, Craig JC, Polkinghorne KR, Atkins RC, Chadban SJ. Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis. 2011;58:19\u201328.","journal-title":"Am J Kidney Dis"},{"key":"1943_CR30","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.ki.5000284","volume":"69","author":"F Irie","year":"2006","unstructured":"Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006;69:1264\u201371.","journal-title":"Kidney Int"},{"key":"1943_CR31","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689\u201399.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1943_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377\u201399.","journal-title":"Stat Med"},{"key":"1943_CR33","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2018-01041","volume":"103","author":"Z Guo","year":"2018","unstructured":"Guo Z, Poglitsch M, McWhinney BC, Ungerer JPJ, Ahmed AH, Gordon RD, et al. Aldosterone LC-MS\/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism. J Clin Endocrinol Metab. 2018;103:3965\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"1943_CR34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","volume":"39","author":"A Vaidya","year":"2018","unstructured":"Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev. 2018;39:1057\u201388.","journal-title":"Endocr Rev"},{"key":"1943_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004872-200201000-00003","volume":"20","author":"PO Lim","year":"2002","unstructured":"Lim PO, Struthers AD, MacDonald TM. The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? J Hypertens. 2002;20:11\u201315.","journal-title":"J Hypertens"},{"key":"1943_CR36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11906-003-0012-2","volume":"5","author":"MF Neves","year":"2003","unstructured":"Neves MF, Schiffrin EL. Aldosterone: a risk factor for vascular disease. Curr Hypertens Rep. 2003;5:59\u201365.","journal-title":"Curr Hypertens Rep"},{"key":"1943_CR37","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","volume":"31","author":"A Tomaschitz","year":"2010","unstructured":"Tomaschitz A, Pilz S, Ritz E, Meinitzer A, Boehm BO, M\u00e4rz W. Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Eur Heart J. 2010;31:1237\u201347.","journal-title":"Eur Heart J"},{"key":"1943_CR38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/jhh.2014.20","volume":"28","author":"K Nanba","year":"2014","unstructured":"Nanba K, Tsuiki M, Nakao K, Nanba A, Usui T, Tagami T, et al. A subtype prediction score for primary aldosteronism. J Hum Hypertens. 2014;28:716\u201320.","journal-title":"J Hum Hypertens"},{"key":"1943_CR39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1507\/endocrj.EJ20-0329","volume":"68","author":"N Wada","year":"2021","unstructured":"Wada N, Miyoshi A, Usubuchi H, Terae S, Shibayama Y, Takahashi B, et al. Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism. Endocr J. 2021;68:45\u201351.","journal-title":"Endocr J"},{"key":"1943_CR40","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/cen.13278","volume":"86","author":"H Kobayashi","year":"2017","unstructured":"Kobayashi H, Haketa A, Ueno T, Ikeda Y, Hatanaka Y, Tanaka S, et al. Scoring system for the diagnosis of bilateral primary aldosteronism in the outpatient setting before adrenal venous sampling. Clin Endocrinol. 2017;86:467\u201372.","journal-title":"Clin Endocrinol"},{"key":"1943_CR41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-14-1013","volume":"172","author":"M Weigel","year":"2015","unstructured":"Weigel M, Riester A, Hanslik G, Lang K, Willenberg HS, Endres S, et al. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism. Eur J Endocrinol. 2015;172:443\u201350.","journal-title":"Eur J Endocrinol"},{"key":"1943_CR42","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/ajh\/hpz098","volume":"32","author":"C-H Wu","year":"2019","unstructured":"Wu C-H, Wu V, Yang Y-W, Lin Y-H, Yang S-Y, Lin P-C, et al. Plasma aldosterone after seated saline infusion test outperforms captopril test at predicting clinical outcomes after adrenalectomy for primary aldosteronism. Am J Hypertens. 2019;32:1066\u201374.","journal-title":"Am J Hypertens"},{"key":"1943_CR43","doi-asserted-by":"crossref","DOI":"10.1177\/1470320320972032","volume":"21","author":"Q Xiang","year":"2020","unstructured":"Xiang Q, Wang W, Chen T, Yu K, Li Q, Zhang T, et al. The value of the post-captopril aldosterone\/renin ratio for the diagnosis of primary aldosteronism and the influential factors: a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2020;21:1470320320972032.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1943_CR44","doi-asserted-by":"crossref","unstructured":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024;105:s117\u2013s314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"1943_CR45","first-page":"e563","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e563\u2013e95.","journal-title":"Circulation"},{"key":"1943_CR46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3803\/EnM.2023.1789","volume":"38","author":"J Ha","year":"2023","unstructured":"Ha J, Park JH, Kim KJ, Kim JH, Jung KY, Lee J, et al. 2023 Korean Endocrine Society consensus guidelines for the diagnosis and management of primary aldosteronism. Endocrinol Metab. 2023;38:597\u2013618.","journal-title":"Endocrinol Metab"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01943-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01943-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01943-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:03:22Z","timestamp":1738710202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01943-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01943-w","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}